Google search results for abortion services promote anti-abortion centers
When users seek facilities for the procedure, Google Maps often presents crisis pregnancy centers that discourage abortions Google search results for abortion services promote anti-abortion centers When users seek facilities for the procedure, Google Maps often presents crisis pregnancy centers that discourage abortions Sam Levin in San Francisco Email First … Continue reading →
Julia Louis-Dreyfus Is ‘Ready To Rock’ After Surgery Here’s Her Big ‘Fuck You’ To Cancer!
Can’t keep Julia Louis-Dreyfus down!! On Wednesday, the Veep actress gave another update on her battle with cancer — this time posting a FAB “post-op photo” after surgery. Slaying!
Dream catchers, succulents and joints: a visit to an LA cannabis shop
Catering to wealthy people, todays dispensaries aim to present the drug as part of a healthy lifestyle Cannabis Dream catchers, succulents and joints: a visit to an LA cannabis shop Catering to wealthy people, todays dispensaries aim to present the drug as part of a healthy lifestyle @alexhalperin Last modified … Continue reading →
We Took A Scientific Look At Whether Weed Or Alcohol Is Worse For You – And There Appears To Be A Clear Winner
Which is worse for you: weed or whiskey? It’s a tough call, but based on the science, there appears to be a clear answer. Keep in mind that there are dozens of factors to account for, including how the substances affect your heart, brain, and behavior, and how likely you … Continue reading →
Ultra-processed foods may be linked to cancer, says study
Findings suggest increased consumption of ultra-processed foods tied to rise in cancers, but scientists say more research is needed Ultra-processed foods may be linked to cancer, says study Findings suggest increased consumption of ultra-processed foods tied to rise in cancers, but scientists say more research is needed Sarah Boseley Health … Continue reading →
New cancer test isn’t ready for prime time
(CNN)A simple blood test to detect cancer early. How great is that? The task at hand is particularly challenging. We all have pieces of DNA in our blood. Distinguishing the tumor DNA from the background DNA requires finding the mutations specifically associated with cancer. Adding to the complexity, healthy individuals … Continue reading →
Talk is cheap: the myth of the focus group
The long read: Focus groups make us feel our views matter but no one with power cares what we think In the early 1950s, the Betty Crocker company had a problem: American housewives liked the idea of cake mix, but they werent actually buying it. And so the company approached … Continue reading →
86% of Teens Have These Toxic Chemicals in Their Bodies
Research published Monday in the journal BMJ Open revealed some frightening statistics about the incidence of Bisphenol A (BPA) among teenagers: press statement. Welpanyone whos had a long day and wants to just nuke some food in a microwave could be getting a dose of BPA to boot. And while … Continue reading →
Food may influence cancer spread
Spread The study, conducted at the Cancer Research UK Cambridge Institute, took place on mice with an aggressive form of breast cancer. Normally they would die in a couple of weeks as the tumour spread throughout the body. But when the mice were given a low-asparagine diet or drugs to … Continue reading →
Spread of breast cancer linked to compound in asparagus and other foods
Using drugs or diet to reduce levels of asparagine may benefit patients, say researchers Spread of breast cancer linked to compound in asparagus and other foods Using drugs or diet to reduce levels of asparagine may benefit patients, say researchers Ian Sample Science editor Wed 7 Feb 2018 13.00EST Share … Continue reading →
In order to be able to screen patients who are suspecting breast cancer, breast MRI is being resorted to be many doctors. In the modern day world, there has been a fair amount of advancement in the field of medical science and the same has ensured that ailments get discovered at the earliest. Getting to know of the existence of breast cancer in the early stages ensures that the same can be addressed and the patient treated for the same. A breast MRI has become one of the better and more sure shot ways of detecting breast cancer.
Making best use of breast MRI scanning process will lead towards realizing advanced healthcare because of which you will be able to realize perfect health standards on the whole. Based upon a comprehensive imaging process involving magnetic resonance system, the latest breast MRI scanning process is known to detect the signs of breast cancer in women early. Obtaining an effective treatment based upon the results obtained will be helpful in realizing
Women may also help themselves with healthy habits that might help breast cancer prevention, including regular moderate exercise, keeping a healthful weight, and avoBreast-MRI-Breast-MRI-exam-Orange-County-Murrieta-1024x610iding excessive alcohol. Generally, acquiring a wholesome diet and way of life reduces an individual’s chance of growing cancer. Factors that might help breast cancer
"Breast cancer isn't a single entity but instead a heterogeneous group of numerous disease subtypes. There are 3 ways that breast cancer can recur. In addition it's helpful for staging breast cancer to ascertain the most suitable therapy and for patient follow-up after breast cancer therapy. While MRI is quite a strong and versatile technology, it's not utilized in all conditions. Breast MRI is a very sensitive, noninvasive diagnostic tool which is often used together with mammography and ultrasound. A breast MRI isn't painful."
In December my younger sister Sarah died of lung cancer, two years after first being diagnosed.
She had led an admirably healthy life, didn’t drink and had never smoked.
The disease seemed to come out of nowhere, shattering the life of a brilliant and much loved mum, wife and writer.
Sarah had been working on a historical novel for the past eight years and her death meant that she missed its publication by a few days.
Before her illness I knew very little about lung cancer and probably shared the common view that it was a smoker’s disease.
I had no idea how many healthy people who had never smoked got it, and how in the UK it kills more people than breast, prostate and pancreatic cancer combined.
Sarah’s cancer was caused by a non-inherited genetic mutation.
She was treated with a number of the relatively new targeted drugs available.
What was so frustrating was that when they worked they could shrink a tumour the size of an orange to nothing.
But Sarah was particularly unlucky.
With some people these drugs work well for quite some time, but the nature of her cancer meant that she burned through a number of them very quickly.
When the drug stops working, the tumours spring back almost immediately to the size they were before – or worse.
Like my sister, Joanna Marshall is a young mother to two children, has never smoked, and yet has stage four lung cancer because of a non-inherited fault in her genes.
She has also been treated with targeted drug therapies.
“They provide a very effective stay of execution. So for me, for example, I have been on a targeted therapy for about a year which meant that I could live essentially a normal life,” she said.
“I was very active. I could breathe properly but they don’t last for ever. The problem is that cancer tends to be one step ahead.
“My husband – his life has completely changed and it’s not what I wanted for him; but you know, if we get through this, we’ll be so strong,” she added.
According to the leading medical charity Cancer Research UK (CRUK), 98 people die of lung cancer in the UK each day – making it the country’s biggest cancer killer.
In around 14% of cases, those who get the disease have never smoked.
Despite this, there is no screening programme for the disease, something which the Roy Castle Lung Cancer Foundation, the UK’s only charity exclusively dedicated to lung cancer, is campaigning for.
Cancer Research says there is no national programme in part because it is not clear that screening would save lives, the tests have risks and they can be expensive.
Plus, there is a concern screening could cause over-diagnosis – meaning some people may have treatment they do not need.
Dr David Gilligan, a consultant oncologist at Addenbrookes and Papworth hospitals in Cambridge, says late diagnosis is a disaster for patients.
“It’s a massive problem because these people who are diagnosed with lung cancer and have never smoked are really quite angry that they are assumed to have smoked and they have self-inflicted this cancer… when clearly they haven’t,” he said.
“Because of the way that the disease behaves, and that these people are not expected to be diagnosed with lung cancer, they are not high risk, they are usually diagnosed at a later stage and therefore treatment can often not be curative, which is a complete and utter disaster for them.”
Most lung cancers are diagnosed at stage four, which means that the tumours have spread.
Sufferers often experience no symptoms and many of them are first diagnosed when they present at Accident and Emergency departments.
The average prognosis is 200 days but if caught early, there is up to a 73% increased chance of surviving over five years.
The British Journal of Cancer predicts that lung cancer cases in the UK will double from 65,000 in 2010 to 137,000 in 2040 and that women will be worst affected.
The number of women with lung cancer is expected to almost quadruple within the next 30 years, from around 26,000 in 2010 to about 95,000 in 2040.
In contrast, the figures for men are predicted to increase by 8%, from 39,000 to 42,000 over the same period.
However, partly due to the negative associations of smoking, lung cancer remains the poor relation in the cancer family.
It receives a fraction of the research funding of other cancers.
Just £708 is spent on research per lung cancer death, compared with £3,570 for breast cancer, £7,640 for leukaemia and £10,116 for testicular cancer.
The entertainer and host of BBC TV’s “Record Breakers” Roy Castle, also a lifelong non-smoker, died of lung cancer in 1994.
Paula Chadwick, chief executive of the Roy Castle Lung Cancer Foundation, paints a stark picture of why research and treatment is so poorly funded.
She argues that it is almost a “Cinderella” disease, because of the stigma that comes with the idea that it might be self-inflicted.
“A lot of patients believe that it is their fault as well,” she says.
“But it doesn’t matter if you are a smoker, non-smoker, or ex-smoker, if you have lungs you can get lung cancer, it does not discriminate.
“Sadly we don’t have that army of advocates or those ex-patients who can help us raise the profile because it does have poor survival rates, she adds.
A cure or effective long-term drug therapy for lung cancer in both smokers and non-smokers remains a way off.
There will be many more cases like that of my sister Sarah before this disease, which can strike down healthy young people indiscriminately, is tackled and beaten.
Watch Clive Coleman’s full report on the Six O’Clock News on BBC One this evening.
Stanford Medicine (SM) are doubling-down on their work on so-called “cancer vaccines” – treatments that induce the body’s own immune system to annihilate cancerous cells. Following on from another slightly different vaccine study published earlier this month, this paper describes how stem cells have been used in mice to not just shrink tumors, but in some cases immunize their bodies against future reintroductions of the cancer.
This new work, published in Cell: Stem Cell, relies on the use of induced pluripotent stem cells, or iPSCs. These little wonders are derived from skin or blood cells that have been chemically reprogrammed to return to this primitive state. Given a little technical prodding, they can transform into any type of cell that’s required.
You can see why, given this ability, they’re being considered to game-changers in the world of regenerative, organ-growing research. An SM-led team wondered how they may fair when it comes to treating cancer, so they set to work.
Cancer cells are often left unchecked by immune systems. Despite their abnormalities, they are still our own cells, so they don’t register as foreign invaders. This camouflage means that even if they are identified as a threat, it’s often too late to stop it as their proliferation has spiraled out of control. Immunotherapy hopes to overcome this identification problem.
To wit, the team noticed that the gene expressions – the “on-off” state of a gene or series of genes – of cancer cells and iPSCs were fairly comparable, at least in mice. This suggested that both posses similar proteins on their surfaces, and it was suspected that because of this, the team could use the IPSCs as a warning shot: a passive blueprint that would tell the immune system what exactly it should be seeking to destroy.
In order to confirm the validity of this hypothesis, they injected tumor-bearing mice with genetically-identical IPSCs, irradiated to ensure they didn’t grow uncontrollably into tumors themselves. In some cases, they were also accompanied by an additional immune-stimulating agent.
It worked: given an injection of the IPSCs and the agent once a week for four weeks, the mice’s immune system registered the IPSC surface proteins, and subsequently destroyed the matching cancer cells. Out of 10 breast cancer-riddled mice in this vaccinated group, the tumors shrank in size in seven of them, and two were able to “fully reject” new cancer cells even after they were reintroduced to them a year later, according to the study – evidence of a cancer prevention mechanism at play.
The vaccine also appears to work somewhat effectively on both skin cancer and a particularly difficult-to-treat type named mesothelioma. Each time, the IPSCs had the potential to grow into that specific cancer type, but were irradiated to prevent them from doing so – and in turn, this provided the immune system with a safe way to identify the real threat.
Although the study describes this work as being in the “proof of concept” stage, the potential for this treatment is obvious. If this vaccine could be applied to humans, it may not only shrink or destroy tumors, but prevent future ones from arising, all using cells from the patient’s own body.
“We propose that immunotherapy – and especially our vaccine – be used in conjunction with established therapies,” senior author Prof. Joseph Wu, MD, PhD, director of Stanford’s Cardiovascular Institute, told IFLScience.
“Further development of immunotherapies with increased specificity to the cancer without (or with limited) adverse effects will hopefully one day limit the use of systemic therapies with significant side effects.”
Aimee Eckert, a doctoral researcher focusing on cancer biology at the University of Sussex – and who wasn’t involved in the study – tells IFLScience this is a “promising step,” but at this stage its likeliness to work in a human patient is uncertain.
The study notes risks of an immune system overreaction, as well as the danger of immune cells hidden with the cores of tumors “which are indoctrinated by the cancer cells to be less reactive against other cancer cells.”
So far, the work has only been conducted on mice – a useful but imperfect proxy to people. “They are going to test it on human tissue in a laboratory-based setting next, though, which is exciting,” Eckert noted.
Hoorah! Great doctors, great results, feeling happy and ready to rock after surgery. Hey cancer, “Fuck you!” Here’s my first post op photo. pic.twitter.com/5LPlbzpiI3 — Julia Louis-Dreyfus (@OfficialJLD) February 14, 2018